Wednesday, March 20, 2019 7:41:19 PM
ATIS and GERS are joined at the hip.
The lignin patent is in Attis Innovations name, however, Attis is our strategic partner. ATIS' patents benefit GERS and GERS' patents benefit ATIS. They compliment each other. The combination benefits both GERS and ATIS shareholders.
As an owner of GERS, we will benefit from ATIS' performance and payments.
GERS will own facilities that are based on ATIS', GERS', and Flux patents.
In general, GERS' patents cover various methods/processes.
ATIS' patents produce products from those methods/processes.
In addition to GERS/ATIS technology, Mr. Kreisler contributed $8MM in other patented technologies to the partnership.
https://www.sec.gov/Archives/edgar/data/949721/000121390018007157/f8k052518ex10-1_attisindus.htm
Also, GERS owns 180,000 ATIS series G shares that convert into $18,000,000.
Good Luck To All!$!$
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM